ACAD
36.73
-0.26
-0.70%
AEMD
0.98
+0.01
+1.03%
APRI
1.9
+0.11
+6.15%
ARNA
27.56
+0.71
+2.64%
ATEC
4.13
+0.36
+9.55%
CNAT
5.15
+0.05
+0.98%
CRXM
0.137
-0.018
-11.71613%
CYTX
0.486
+0.016
+3.470%
DXCM
44.95
-0.04
-0.09%
GNMK
8.06
-0.05
-0.62%
HALO
17.72
-0.02
-0.11%
ILMN
205.62
-0.86
-0.42%
INNV
0.09
+0.003
+3.6994%
INO
6.32
+0.08
+1.28%
ISCO
1.51
-0.16
-9.58%
ISIS
57.56
0.00
0.00%
LGND
144.16
+2.01
+1.41%
LPTN
2.93
-2.93
-100.00%
MBVX
0.715
-0.015
-2.082%
MEIP
2.48
+0.15
+6.44%
MNOV
6.38
-0.24
-3.63%
MRTX
14.35
+0.1
+0.70%
MSTX
0.13
-0.01
0.00%
NBIX
59.42
-1.45
-2.38%
NUVA
54.18
+0.47
+0.88%
ONCS
1.28
+0.07
+5.79%
ONVO
1.48
-0.04
-2.63%
OREX
1.87
-0.02
-1.06%
OTIC
3.45
-0.02
-0.72%
QDEL
41.71
+0.35
+0.85%
RCPT
231.96
0.00
0.00%
RGLS
1.32
0.00
0.00%
RMD
78.87
+0.45
+0.57%
SCIE
0
0.00
0.00%
SPHS
2.243
-0.037
-1.6272%
SRNE
2.6
-0.25
-8.77%
TROV
0.868
+0.078
+9.873%
VICL
2.38
-0.15
-5.93%
VOLC
18
0.00
0.00%
ZGNX
39
+0.9
+2.36%
ACAD
36.73
-0.26
-0.70%
AEMD
0.98
+0.01
+1.03%
APRI
1.9
+0.11
+6.15%
ARNA
27.56
+0.71
+2.64%
ATEC
4.13
+0.36
+9.55%
CNAT
5.15
+0.05
+0.98%
CRXM
0.137
-0.018
-11.71613%
CYTX
0.486
+0.016
+3.470%
DXCM
44.95
-0.04
-0.09%
GNMK
8.06
-0.05
-0.62%
HALO
17.72
-0.02
-0.11%
ILMN
205.62
-0.86
-0.42%
INNV
0.09
+0.003
+3.6994%
INO
6.32
+0.08
+1.28%
ISCO
1.51
-0.16
-9.58%
ISIS
57.56
0.00
0.00%
LGND
144.16
+2.01
+1.41%
LPTN
2.93
-2.93
-100.00%
MBVX
0.715
-0.015
-2.082%
MEIP
2.48
+0.15
+6.44%
MNOV
6.38
-0.24
-3.63%
MRTX
14.35
+0.1
+0.70%
MSTX
0.13
-0.01
0.00%
NBIX
59.42
-1.45
-2.38%
NUVA
54.18
+0.47
+0.88%
ONCS
1.28
+0.07
+5.79%
ONVO
1.48
-0.04
-2.63%
OREX
1.87
-0.02
-1.06%
OTIC
3.45
-0.02
-0.72%
QDEL
41.71
+0.35
+0.85%
RCPT
231.96
0.00
0.00%
RGLS
1.32
0.00
0.00%
RMD
78.87
+0.45
+0.57%
SCIE
0
0.00
0.00%
SPHS
2.243
-0.037
-1.6272%
SRNE
2.6
-0.25
-8.77%
TROV
0.868
+0.078
+9.873%
VICL
2.38
-0.15
-5.93%
VOLC
18
0.00
0.00%
ZGNX
39
+0.9
+2.36%
Home » Archive by Category

Syndication

After Trump Sounds Off, Senate Has Adult Conversation on Drug Prices

October 17, 2017 – 11:54 am

In advance of an anticipated Senate hearing on drug prices, President Donald Trump once again denounced drug companies as “getting away with murder.” The first time he did so, using the…

[[Click headline to continue reading.]]

Granulation Technician – $14/hr (Vista)

October 17, 2017 – 11:51 am

PAY:: $14
2nd shift 2pm – 10:30 pm
other shifts are available in similar positions – call for details
General Purpose of Job
‚ÄĘGranulation, Milling Technician will follow and understand granulation, milling procedures and to confirms that all ma …

Entry-level Biochemist

October 17, 2017 – 10:45 am

A MEDICAL DEVICE COMPANY is seeking Manufacturing Techs with ELISA experience! Responsibilities: Manufactures (i.e. Formulates bulks, and Quality Controls) products (i.e. Lateral flow devices, controls/calibrators and microtitre systems) while adhering to

Quality Control – Microbiology

October 17, 2017 – 10:38 am

Pharmaceutical company in Sorrento Valley is seeking QC Microbiologists!! Responsibilities: Conduct routine environmental and systems monitoring of manufacturing and laboratory areas. Conduct general laboratory experimentation in compliance with SOPs and

Next-Generation Release of goBalto Activate Drives Industry Adoption and Momentum

October 17, 2017 – 9:00 am

Key business optimization features and operational enhancements reduce complexities and speed study startup

SAN FRANCISCO, Oct. 17, 2017 /PRNewswire/ — goBalto, Inc., the leading provider of cloud-based clinical study startup (SSU) solutions, announced today its latest release of goBalto Activate. The third major release of 2017 offers new features that further accelerate clinical study startup.

SSU is an array of activities performed at the outset of studies, including: investigative site selection and initiation, regulatory document submission, contract and budget negotiations, and enrolling the first subject. The process of initiating clinical trials remains unwieldy, challenging, and often behind schedule, making SSU one of the poorest performing aspects of clinical trials. At a time when SSU remains a perpetual bottleneck, leading companies are positioning themselves ahead of the curve by embracing solutions that confront these real challenges, thereby emphasizing differentiation and operational efficiencies.

New APIs and functionality in the release allow for the exchange of alert or task information between Activate and the Shared Investigator Platform (SIP), and other industry site portals.

“The enterprise APIs enable other systems or transformation layers to interact with the application data in much the same way that a user would,” said Sujay Jadhav, goBalto‘s CEO. goBalto‘s proven integration points encompass the eClinical suite and business applications (e.g., CTMs, CRM, eTMF, data warehouses) with key integration components (i.e., data staging, business rule compliance, target data staging and API processing) provided to ensure a seamless and successful integration.

“The integration of Activate with SIP is key to ensuring improved efficiencies across the clinical trial process and compliance with evolving industry standards,” said Jadhav. “Activate workflows aid global regulatory and SOP compliance, accelerating site activation, leading to greater cost savings and faster market entry.”

The Configuration Designer functionality in Activate provides a self-service configuration wizard for workflows, providing the flexibility needed to rapidly respond to dynamic regulatory and SOP changes for studies, currently in-progress or planned.

“The enhancements to the application interface, contract management functionality, and others of this most recent release improve overall usability and ease of adoption,” stated Lorena R. Gomez, Director, Global Study Start Up & Essential Documents, Allergan. “It’s clear that goBalto listens to their customers’ feedback and incorporates it into subsequent enhancements.”

With over 300 pharma and CRO companies benefiting through a networked model using Activate to manage, track, and complete study startup tasks in over 2,000 studies, utilizing over 70,000 sites, in 70+ countries, goBalto has the largest industry-proven set of country workflows and associated performance metrics. Standard ‘out-of-the-box’ country specific regulatory business process workflows allow for quick site activation, leading to greater cost savings and faster market entry, making valuable therapies available to patients sooner.

“Today, our SSU platform is embedded into the business processes of leading life science organizations, that take advantage of new releases to enhance overall value. This release illustrates our commitment to our customers as we enhance interoperability with leading portals, and provide new functionality to tackle entrenched pain points in SSU,” said Jadhav. “This release reinforces goBalto‘s leadership position as we continue to provide next-generation, industry proven study startup solutions, which are key to stemming inefficiencies endemic in industry.”

About goBalto

goBalto is the industry leader in cloud-based study startup software for the global life sciences industry, offering the only complete end-to-end platform for starting clinical trials, from site identification, feasibility assessment and selection through to activation, with comprehensive metrics to track adherence to timelines and budget. Committed to accelerating clinical trials through innovation, product excellence, and customer success, goBalto works with four of the top five CROs and more than two-thirds of the top 25 pharmas. Our customers include: Allergan, Covance, CMIC HOLDINGS, Genentech Roche, ICON, INC Research, Novartis, and PSI CRO. goBalto is headquartered in San Francisco, with offices in Philadelphia and Singapore. For more information, visit www.gobalto.com.

Press contact:
Craig Morgan
415.671.4372
cmorgan@gobalto.com

 

View original content with multimedia:http://www.prnewswire.com/news-releases/next-generation-release-of-gobalto-activate-drives-industry-adoption-and-momentum-300537505.html

SOURCE goBalto, Inc.

Microbiologist (Mira Mesa)

October 17, 2017 – 8:59 am

Outstanding Pharmaceutical company seeks candidate to provide technical expertise in the area of pharmaceutical microbiology. The position functions in a cooperative effort to provide quality control and assurance to the operational departments invol …

Inside Sales Associate Position ((Sorrento Valley))

October 17, 2017 – 8:37 am

We are a fast growing company selling chemical linkers and bioconjugation tools to biotech industry internationally. We are looking for an energetic and self-motivated candidate with a positive attitude and work ethic to fill this inside sales associ …

Inside Sales Associate Position ((Sorrento Valley))

October 17, 2017 – 8:37 am

We are a fast growing company selling chemical linkers and bioconjugation tools to biotech industry internationally. We are looking for an energetic and self-motivated candidate with a positive attitude and work ethic to fill this inside sales associ …

Research Associate 2 (S_579492)

October 17, 2017 – 5:44 am

Randstad is seeking a Research Associate 2 for one of its biotechnology clients.This client is a leading developer, manufacturer, and supplier of premium molecular diagnostic products and services that are used to diagnose human diseases, screen dona …

Supervisor, Production – Illumina – San Diego, CA

October 17, 2017 – 4:45 am

The Production Supervisor will directly manage chemists on this high throughput (and high rate of change) biotechnology production line….From Illumina – Tue, 17 Oct 2017 12:45:49 GMT – View all San Diego, CA jobs